Jinhe Biotechnology Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Changxian Xie

Algemeen directeur

CN¥575.9k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	17yrs
Eigendom CEO	0.4%
Management gemiddelde ambtstermijn	10.4yrs
Gemiddelde ambtstermijn bestuur	10yrs

Recente managementupdates

Recent updates

Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

May 27

Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

May 13

Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

May 13

CEO

Changxian Xie (62 yo)

17yrs

Tenure

CN¥575,900

Compensatie

Mr. Changxian Xie serves as General Manager at Jinhe Biotechnology CO., LTD. since November 27, 2007 and serves as its Director since November 27, 2007.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Changxian Xie	GM & Director	17yrs	CN¥575.90k	0.44% CN¥ 14.5m
You Shan Niu	Financial Director	10.3yrs	CN¥306.50k	0.040% CN¥ 1.3m
Zhi Jun Wang	Deputy GM & Director	10.6yrs	CN¥696.00k	geen gegevens
Yueqing Wang	Deputy GM & Non-Independent Director	1.5yrs	CN¥305.90k	0.040% CN¥ 1.3m
Manman Lu	Board Secretary & Director	3.7yrs	CN¥394.80k	1% CN¥ 33.3m
Zhi Sheng Wang	Deputy General Manager	10.6yrs	CN¥246.10k	geen gegevens
Ying Chun Liu	Deputy General Manager	13.9yrs	CN¥307.80k	0.084% CN¥ 2.8m
Yingzhen Guan	Deputy General Manager	7.8yrs	CN¥308.90k	0.040% CN¥ 1.3m

10.4yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 002688 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Changxian Xie	GM & Director	17yrs	CN¥575.90k	0.44% CN¥ 14.5m
Zhi Jun Wang	Deputy GM & Director	10.6yrs	CN¥696.00k	geen gegevens
Yueqing Wang	Deputy GM & Non-Independent Director	1.5yrs	CN¥305.90k	0.040% CN¥ 1.3m
Manman Lu	Board Secretary & Director	1.5yrs	CN¥394.80k	1% CN¥ 33.3m
Dongxiao Wang	Chairman	17yrs	CN¥880.50k	31.96% CN¥ 1.1b
Fu Zhong Li	Vice Chairman of Board of Directors	17yrs	CN¥610.00k	0.74% CN¥ 24.4m
Qian Sui Zhang	Chairman of the Supervisory Board	9.5yrs	geen gegevens	geen gegevens
Jian Xiong Yao	Shareholder Representative Supervisor	10.6yrs	geen gegevens	geen gegevens
Liu Ji Zheng	Employee Representative Supervisor	10.7yrs	geen gegevens	geen gegevens
Minpu Yao	Independent Director	4.5yrs	CN¥82.80k	geen gegevens
Xiaoyan Xie	Independent Director	4.5yrs	CN¥82.80k	geen gegevens
Wenbing Lu	Independent Director	4.5yrs	CN¥82.80k	geen gegevens

10.0yrs

Gemiddelde duur

56.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002688 zijn ervaren en ervaren (gemiddelde ambtstermijn van 10 jaar).

Jinhe Biotechnology Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 12, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.029 (vs CN¥0.018 in 3Q 2023)

Jinhe Biotechnology CO., LTD. to Report Q3, 2024 Results on Oct 28, 2024

Investor sentiment improves as stock rises 20%

Second quarter 2024 earnings released: EPS: CN¥0.059 (vs CN¥0.067 in 2Q 2023)

Jinhe Biotechnology CO., LTD. to Report First Half, 2024 Results on Aug 29, 2024

Investor sentiment deteriorates as stock falls 16%

Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

Dividend of CN¥0.10 announced

Jinhe Biotechnology CO., LTD. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 31 May 2024

Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 20, 2024

Jinhe Biotechnology CO., LTD. to Report Q1, 2024 Results on Apr 29, 2024

Less than half of directors are independent

Jinhe Biotechnology CO., LTD. (SZSE:002688) announces an Equity Buyback for CNY 100 million worth of its shares.

Jinhe Biotechnology CO., LTD. to Report Fiscal Year 2023 Results on Apr 29, 2024

Jinhe Biotechnology CO., LTD. Approves Change of Accounting Policies

Third quarter 2023 earnings released: EPS: CN¥0.018 (vs CN¥0.02 in 3Q 2022)

Less than half of directors are independent

Jinhe Biotechnology CO., LTD. to Report Q3, 2023 Results on Oct 30, 2023

Second quarter 2023 earnings released: EPS: CN¥0.067 (vs CN¥0.072 in 2Q 2022)

Jinhe Biotechnology CO., LTD. to Report First Half, 2023 Results on Aug 23, 2023

Jinhe Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023

Jinhe Biotechnology CO., LTD. announced that it expects to receive CAD 124.8 million in funding from Jinhe Youben Biological Products Co., Ltd.

First quarter 2023 earnings released: EPS: CN¥0.047 (vs CN¥0.04 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.012 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.072 (vs CN¥0.049 in 2Q 2021)

Jinhe Biotechnology CO., LTD. (SZSE:002688) commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 12, 2022.

Less than half of directors are independent

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 12, 2022

Third quarter 2021 earnings released: EPS CN¥0.012 (vs CN¥0.011 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.049 (vs CN¥0.061 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.09 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥0.29 in FY 2019)

New 90-day high: CN¥6.48

Jinhe Biotechnology CO., LTD. to Report Fiscal Year 2020 Results on Mar 31, 2021

Investor sentiment improved over the past week

New 90-day low: CN¥5.27

New 90-day low: CN¥5.71

Third quarter earnings released

New 90-day low: CN¥6.70

Jinhe Biotechnology CO., LTD. to Report Q3, 2020 Results on Oct 20, 2020

New 90-day low: CN¥6.84

Earnings released

Jinhe Biotechnology CO., LTD. to Report First Half, 2020 Results on Aug 24, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd